AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 75 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $53,000 | +120.8% | 1,579 | +45.1% | 0.00% | – |
| Q3 2019 | $24,000 | +242.9% | 1,088 | +204.8% | 0.00% | – |
| Q2 2019 | $7,000 | -22.2% | 357 | +0.3% | 0.00% | – |
| Q1 2019 | $9,000 | +12.5% | 356 | +10.6% | 0.00% | – |
| Q4 2018 | $8,000 | +700.0% | 322 | +820.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 35 | +6.1% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 33 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,967,900 | $42,933,000 | 29.35% |
| TLP GROUP LLC | 2,833,285 | $30,656,000 | 20.86% |
| Aisling Capital LLC | 2,990,000 | $32,352,000 | 7.64% |
| Vivo Capital, LLC | 763,009 | $8,256,000 | 2.26% |
| RA Capital Management | 1,292,940 | $13,990,000 | 1.94% |
| Foresite Capital Management III, LLC | 235,020 | $2,543,000 | 1.74% |
| Palo Alto Investors LP | 325,599 | $3,523,000 | 0.27% |
| Rock Springs Capital Management LP | 293,000 | $3,170,000 | 0.24% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 332,625 | $3,599,000 | 0.20% |
| Virtus ETF Advisers LLC | 19,501 | $211,000 | 0.16% |